You are here: Home > Institute of Excellence (CPD) > CPD Events > Real World Perspective: Evidence Shaping the Treatment of Severe Keratitis in Dry Eye Disease

Real World Perspective: Evidence Shaping the Treatment of Severe Keratitis in Dry Eye Disease

Date: 29/03/2023 (ACDT)

Venue: National Wine Centre of Australia, Corner of Hackney & Botanic Roads, SA 5000

Provider: CSL Seqirus

Contact: Daniel Yu, [E] daniel.yu@seqirus.com, [P] 0427 769 539

Learning Objectives

  • Understand how to escalate treatment in patients with dry eye disease with severe keratitis with ciclosporin eye drops.
  • Gain insight into the relevance of real-world evidence to help guide the practical management of patients with ciclosporin eye drops, specifically Ciclosporin 0.1% eye drops.
  • Know the pathways for applying for PBS Authority application for Ikervis (ciclosporin 0.1% eye drops), where eligible.

Max CPD hours awarded: 1.5

Session Information

Name
A closer look at ciclosporin eye drops & Ikervis® case studies in Australia
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
PERSPECTIVE Study: Real-World Evidence of Ikervis® effectiveness, tolerability and safety
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
Live Q & A Panel: Real world insights
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.